770 research outputs found

    Nitric oxide function in atherosclerosis

    Get PDF
    Atherosclerosis is a chronic inflammatory process in the intima of conduit arteries, which disturbs the endothelium-dependent regulation of the vascular tone by the labile liposoluble radical nitric oxide (NO) formed by the constitutive endothelial nitric oxide synthase (eNOS). This defect predisposes to coronary vasospasm and cardiac ischaemia, with anginal pain as the typical clinical manifestation. It is now appreciated that endothelial dysfunction is an early event in atherogenesis and that it may also involve the microcirculation, in which atherosclerotic lesions do not develop. On the other hand, the inflammatory environment in atherosclerotic plaques may result in the expression of the inducible NO synthase (iNOS) isozyme. Whether the dysfunction in endothelial NO production is causal to, or the result of, atherosclerotic lesion formation is still highly debated. Most evidence supports the hypothesis that constitutive endothelial NO release protects against atherogenesis e.g. by preventing smooth muscle cell proliferation and leukocyte adhesion. Nitric oxide generated by the inducible isozyme may be beneficial by replacing the failing endothelial production but excessive release may damage the vascular wall cells, especially in combination with reactive oxygen intermediates

    Modulation of nitric oxide synthase activity in macrophages

    Get PDF
    L-Arginine is converted to the highly reactive and unstable nitric oxide (NO) and L-citrulline by an enzyme named nitric oxide synthase (NOS). NO decomposes into other nitrogen oxides such as nitrite (NO2-) and nitrate (NO2-), and in the presence of superoxide anion to the potent oxidizing agent peroxynitrite (ONOO−). Activated rodent macrophages are capable of expressing an inducible form of this enzyme (iNOS) in response to appropriate stimuli, i.e., lipopolysaccharide (LPS) and interferon-γ (IFNγ). Other cytokines can modulate the induction of NO biosynthesis in macrophages. NO is a major effector molecule of the anti-microbial and cytotoxic activity of rodent macrophages against certain micro-organisms and tumour cells, respectively. The NO synthesizing pathway has been demonstrated in human monocytes and other cells, but its role in host defence seems to be accessory. A delicate functional balance between microbial stimuli, host-derived cytokines and hormones in the microenvironment regulates iNOS expression. This review will focus mainly on the known and proposed mechanisms of the regulation of iNOS induction, and on agents that can modulate NO release once the active enzyme has been expressed in the macrophage

    Pricing High Growth Firms: Arbitrage Opportunities in the Inc. 100

    Get PDF
    The ability of the market to price high growth stocks is examined by analyzing the returns to simple investment portfolio strategies based on public information. The portfolios consist of shares in the firms listed in the Inc. 100 Ranking of the fastest growing public companies in America. The results indicate that significant abnormal returns are generated by these strategies, even after adjusting for risk. Although the tests could potentially be affected by a form of survivorship bias, supplementary analyses indicate that this is unlikely to be the case here. These results support the assumption that markets have difficulties pricing high-growth entities, leaving significant arbitrage opportunities in these stocks and validating the use of various market timing practices

    Wireless flow-sensor to inspect spray rate controllers

    Get PDF
    In Belgium, the mandatory inspection of sprayers was already started up in 1996 and the 8th inspection cycle (2017-2018-2019) is currently running. The inspection of sprayers is performed by official and mobile teams ruled by two inspection authorities and the management is done by the Federal Ministry for Consumer Protection, Public Health and the Environment (FAVV). In the Flemish region the inspection is delegated to the Institute for Agricultural and Fisheries Research (ILVO). In the past decade the number of field crop sprayers equipped with a spray rate controller increased significantly. In the first inspection cycle (1996-1998), only 4.58% of the field crop sprayers were equipped with a spray rate controller in Flanders. In the 7th inspection cycle (2014-2016), this percentage increased significantly to 26.92%. As the original inspection method for spray rate controllers showed some lacks and was time consuming, ILVO developed a simple and reliable method to test rate controllers on field crop and orchard sprayers.In Belgium, the mandatory inspection of sprayers was already started up in 1996 and the 8th inspection cycle (2017-2018-2019) is currently running. The inspection of sprayers is performed by official and mobile teams ruled by two inspection authorities and the management is done by the Federal Ministry for Consumer Protection, Public Health and the Environment (FAVV). In the Flemish region the inspection is delegated to the Institute for Agricultural and Fisheries Research (ILVO). In the past decade the number of field crop sprayers equipped with a spray rate controller increased significantly. In the first inspection cycle (1996-1998), only 4.58% of the field crop sprayers were equipped with a spray rate controller in Flanders. In the 7th inspection cycle (2014-2016), this percentage increased significantly to 26.92%. As the original inspection method for spray rate controllers showed some lacks and was time consuming, ILVO developed a simple and reliable method to test rate controllers on field crop and orchard sprayers

    Recent Decisions

    Get PDF
    Comments on recent decisions by Robert R. Waterson, Hugh E. Wall, Francis W. Matthys, Granville P. Ziegler, Thomas H. Nelson, Stanley A. Rosenstein, and John M. Doyle

    Nitric oxide function in atherosclerosis

    Full text link

    Physical and chemical characterisation of some silicas and silica derivatives

    Get PDF
    An extensive study of four types of porous silica supports has been performed, with particular emphasis on their physical and morphological characteristics. These silicas were modified by reacting the surface silanol groups present with either 3-(trimethoxysilyl)propylmethacrylate or 3-glycidoxypropyltrimethoxysilane or 3-aminopropyltriethoxysilane, to produce derivatives with suitable functional groups for further utilisation in the immobilisation of biological compounds. The silicas and their derivatives used were fully characterised with regard to particle size distribution (laser light scattering), specific surface area (BET method), pore size distribution (gas adsorption and mercury porosimetry), density (helium pycnometry), yield of grafting (TGA) and chemical composition (FTIR/DRIFT).http://www.sciencedirect.com/science/article/B6TH9-3TXCN74-C/1/0c8b28b8c7165139b2661a2e21e0355

    Oxidized Lipoproteins Suppress Nitric Oxide Synthase in Macrophages: Study of Glucocorticoid Receptor Involvement

    Get PDF
    Activated cholesterol-laden macrophages in atherosclerotic lesions are believed to influence the progression of this disease. The induction of nitric oxide synthase (iNOS) activity was investigated in control and cholesterol-laden J774 macrophages, obtained by pre-incubation with oxidized or acetylated low density lipoproteins (oxLDL, acLDL). Loading with oxLDL caused a small induction of NOS activity in unstimulated cells, as indicated by nitrite and citrulline accumulation in the supernatant. However, it suppressed the iNOS activity resulting from stimulation of the cells with lipopolysaccharide with or without interferon-γ. AcLDL had no inhibitory effect, indicating that cholesterol accumulation as such was not responsible. Since the induction of NOS in macrophages is inhibited by glucocorticoids, the possibility that a glucocorticoid-like factor, formed during oxidation of LDL, may cause the inhibition, was investigated. However, addition of the glucocorticoid receptor antagonist mifepristone did not prevent the oxLDL-dependent NOS inhibition, indicating that the glucocorticoid receptor is not involved in the suppressive effect of oxLDL
    • …
    corecore